298 related articles for article (PubMed ID: 31542869)
21. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
[TBL] [Abstract][Full Text] [Related]
22. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
Lu S; Zhang J
J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
[TBL] [Abstract][Full Text] [Related]
23. SAR studies on mGlu5 receptor positive allosteric modulators (2003- 2013).
Hao J; Xiong H
Curr Top Med Chem; 2014; 14(15):1789-841. PubMed ID: 25176124
[TBL] [Abstract][Full Text] [Related]
24. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
Bhunia SS; Saxena AK
Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
[TBL] [Abstract][Full Text] [Related]
25. Allosteric activation of metabotropic glutamate receptor 5.
Jójárt B; Orgován Z; Márki Á; Pándy-Szekeres G; Ferenczy GG; Keserű GM
J Biomol Struct Dyn; 2020 Jun; 38(9):2624-2632. PubMed ID: 31258022
[TBL] [Abstract][Full Text] [Related]
26. Understanding Exposure-Receptor Occupancy Relationships for Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators across a Range of Preclinical and Clinical Studies.
Bennett KA; Sergeev E; MacSweeney CP; Bakker G; Cooper AE
J Pharmacol Exp Ther; 2021 Apr; 377(1):157-168. PubMed ID: 33541889
[TBL] [Abstract][Full Text] [Related]
27. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.
Tarcsay A; Paragi G; Vass M; Jójárt B; Bogár F; Keserű GM
J Chem Inf Model; 2013 Nov; 53(11):2990-9. PubMed ID: 24116387
[TBL] [Abstract][Full Text] [Related]
28. Detailed In Vitro Pharmacological Characterization of Clinically Tested Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5.
Arsova A; Møller TC; Vedel L; Hansen JL; Foster SR; Gregory KJ; Bräuner-Osborne H
Mol Pharmacol; 2020 Jul; 98(1):49-60. PubMed ID: 32358164
[TBL] [Abstract][Full Text] [Related]
29. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.
Johnson MP; Nisenbaum ES; Large TH; Emkey R; Baez M; Kingston AE
Biochem Soc Trans; 2004 Nov; 32(Pt 5):881-7. PubMed ID: 15494040
[TBL] [Abstract][Full Text] [Related]
30. Virtual Screening and Molecular Dynamics Study of Potential Negative Allosteric Modulators of mGluR1 from Chinese Herbs.
Jiang L; Zhang X; Chen X; He Y; Qiao L; Zhang Y; Li G; Xiang Y
Molecules; 2015 Jul; 20(7):12769-86. PubMed ID: 26184151
[TBL] [Abstract][Full Text] [Related]
31. Importance of protein dynamics in the structure-based drug discovery of class A G protein-coupled receptors (GPCRs).
Lee Y; Lazim R; Macalino SJY; Choi S
Curr Opin Struct Biol; 2019 Apr; 55():147-153. PubMed ID: 31102980
[TBL] [Abstract][Full Text] [Related]
32. Biased agonism and allosteric modulation of metabotropic glutamate receptor 5.
Trinh PNH; May LT; Leach K; Gregory KJ
Clin Sci (Lond); 2018 Nov; 132(21):2323-2338. PubMed ID: 30389826
[TBL] [Abstract][Full Text] [Related]
33. Shining Light on an mGlu5 Photoswitchable NAM: A Theoretical Perspective.
Dalton JA; Lans I; Rovira X; Malhaire F; Gómez-Santacana X; Pittolo S; Gorostiza P; Llebaria A; Goudet C; Pin JP; Giraldo J
Curr Neuropharmacol; 2016; 14(5):441-54. PubMed ID: 26391742
[TBL] [Abstract][Full Text] [Related]
34. Allosteric Modulators of the Class A G Protein Coupled Receptors.
Tschammer N
Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
[TBL] [Abstract][Full Text] [Related]
35. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
Burford NT; Watson J; Bertekap R; Alt A
Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
[TBL] [Abstract][Full Text] [Related]
36. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
[TBL] [Abstract][Full Text] [Related]
37. Structural insight to mutation effects uncover a common allosteric site in class C GPCRs.
Harpsøe K; Boesgaard MW; Munk C; Bräuner-Osborne H; Gloriam DE
Bioinformatics; 2017 Apr; 33(8):1116-1120. PubMed ID: 28011766
[TBL] [Abstract][Full Text] [Related]
38. Exploring the Binding Mechanism of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators in Clinical Trials by Molecular Dynamics Simulations.
Fu T; Zheng G; Tu G; Yang F; Chen Y; Yao X; Li X; Xue W; Zhu F
ACS Chem Neurosci; 2018 Jun; 9(6):1492-1502. PubMed ID: 29522307
[TBL] [Abstract][Full Text] [Related]
39. Repositioning Dequalinium as Potent Muscarinic Allosteric Ligand by Combining Virtual Screening Campaigns and Experimental Binding Assays.
Mazzolari A; Gervasoni S; Pedretti A; Fumagalli L; Matucci R; Vistoli G
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825082
[TBL] [Abstract][Full Text] [Related]
40. Agonists and allosteric modulators promote signaling from different metabotropic glutamate receptor 5 conformations.
Nasrallah C; Cannone G; Briot J; Rottier K; Berizzi AE; Huang CY; Quast RB; Hoh F; Banères JL; Malhaire F; Berto L; Dumazer A; Font-Ingles J; Gómez-Santacana X; Catena J; Kniazeff J; Goudet C; Llebaria A; Pin JP; Vinothkumar KR; Lebon G
Cell Rep; 2021 Aug; 36(9):109648. PubMed ID: 34469715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
